Zobrazeno 1 - 10
of 53
pro vyhledávání: '"H. Fretheim"'
Autor:
Gunnstein Bakland, Elizabeth R Volkmann, Dinesh Khanna, Oliver Distler, Anna-Maria Hoffmann-Vold, Øyvind Midtvedt, Øyvind Molberg, Alvilde Dhainaut, Vikas K Sarna, Håvard H Fretheim, Imon Barua, Maylen N Carstens, Henriette Didriksen, Anne-Kristine Halse, Maiju Pesonen, Inge Olsen
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Introduction In the multisystem inflammatory disorder systemic sclerosis (SSc), gastrointestinal tract (GIT) affliction is highly prevalent. There are no known disease modifying therapies and the negative impact is substantial. Aiming for a new thera
Externí odkaz:
https://doaj.org/article/da9f8b1d4122456db6b1e883d2e677c3
Autor:
A M Hoffmann-Vold, H Fretheim, P P Diep, K Lerang, H Andersson, Ø Midtvedt, T Garen, M Durheim, T M Aaløkken, Ø Palm, Ø Molberg
Publikováno v:
12.02 - ILD/DPLD of known origin.
Autor:
H J Bjørkekjær, C Bruni, P E Carreira, P Airò, C Simeón-Aznar, M Truchetet, A Giollo, A Balbir-Gurman, M Martin, C Denton, A Gabrielli, H Fretheim, I Barua, H Bitter, Ø Midtvedt, K Broch, A K Andreassen, Y Tanaka, G Riemekasten, U Müller-Ladner, M Matucci Cerinic, I Castellví, E Siegert, E Hachulla, O Distler, A Hoffmann-Vold
Publikováno v:
13.01 - Pulmonary hypertension.
Autor:
H. Fretheim, I. Barua, Ø. Midtvedt, T. Garen, P. P. Diep, M. Durheim, C. Brunborg, A. M. Hoffmann-Vold
Publikováno v:
Annals of the Rheumatic Diseases. 81:729.2-730
BackgroundSpirometry, in particular forced vital capacity (FVC), is a widely implemented tool in the initial diagnostic workup and monitoring of systemic sclerosis-related interstitial lung disease (SSc-ILD). In addition to ILD, several other extra-p
Autor:
A. M. Hoffmann-Vold, H. Fretheim, P. P. Diep, K. Lerang, H. Andersson, Ø. Midtvedt, T. Garen, M. Durheim, T. M. Aaløkken, Ø. Palm, Ø. Molberg
Publikováno v:
Annals of the Rheumatic Diseases. 81:249.3-249
BackgroundInterstitial lung disease (ILD) in primary Sjögren’s syndrome (pSS) has been reported to be present in 10-15% of patients, but pSS-ILD behavior over time is not well characterized.ObjectivesAssess the pattern of ILD in pSS, its disease b
Autor:
I. Barua, V. Palchevskiy, H. Fretheim, H. Didriksen, T. Garen, T. M. Aaløkken, S. S. Weigt, Ø. Molberg, J. Belperio, A. M. Hoffmann-Vold
Publikováno v:
Annals of the Rheumatic Diseases. 81:762.1-762
BackgroundSystemic sclerosis (SSc) carries a high risk for progressive interstitial lung disease (ILD). Several anti-inflammatory therapies have been used to treat SSc-ILD and recently the first antifibrotic therapy has been approved. Personalized tr
Autor:
M. Scheidegger, A. Garaiman, C. Mihai, M. O. Becker, R. Dobrota, C. Bruni, S. Jordan, H. Fretheim, Ø. Midtvedt, H. J. Bjørkekjær, I. Barua, A. M. Hoffmann-Vold, O. Distler, M. Elhai
Publikováno v:
Annals of the Rheumatic Diseases. 81:735.2-736
BackgroundInterstitial lung disease (ILD) is the leading cause of death in systemic sclerosis (SSc). European consensus guidelines consider that some patients with mild disease might not need pharmacological treatment (1). Up to now, the disease char
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W. Wu, S. Jordan, M.O. Becker, R. Dobrota, B. Maurer, H. Fretheim, S. Ye, E. Siegert, Y. Allanore, A.M. Hoffmann-Vold, O. Distler
Publikováno v:
FRIDAY, 15 JUNE 2018.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.